New Key Statistics Module, Z-Score and F-Score
NYSE:GSK Key Ratios
Market Cap $ M | 91,510.77 |
Enterprise Value $ M | 108,051.02 |
P/E(ttm) | 17.65 |
PE Ratio without NRI | 15.95 |
Forward PE Ratio | 11.34 |
Price/Book | 5.26 |
Price/Sales | 2.50 |
Price/Free Cash Flow | 14.27 |
Price/Owner Earnings | 13.00 |
Payout Ratio % | 0.52 |
Revenue (TTM) $ M | 38,694.00 |
EPS (TTM) $ | 2.54 |
Beneish M-Score | -2.69 |
10-y EBITDA Growth Rate % | 1.10 |
5-y EBITDA Growth Rate % | 1.00 |
y-y EBITDA Growth Rate % | -6.50 |
EV-to-EBIT | 13.87 |
EV-to-EBITDA | 10.23 |
PEG | 15.95 |
Shares Outstanding M | 2,039.01 |
Net Margin (%) | 14.59 |
Operating Margin % | 21.97 |
Pre-tax Margin (%) | 17.93 |
Quick Ratio | 0.58 |
Current Ratio | 0.87 |
ROA % (ttm) | 7.56 |
ROE % (ttm) | 34.58 |
ROIC % (ttm) | 12.07 |
Dividend Yield % | 3.30 |
Altman Z-Score | 1.97 |
GSK Number of Guru Trades
GSK Volume of Guru Trades
Gurus Latest Trades with NYSE:GSK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:GSK is held by these investors
Total 6
GSK PLC Insider Transactions
No Available Data
News about NYSE:GSK
Total 0- 1